Receiver operating characteristic (ROC) analysis revealed that LDHA+/CD9+EVs and S100A8/9+/CD9+EVs exhibited favorable diagnostic potential for distinguishing between recurrent and non-recurrent GBM patients post-surgery. Here, CD9 is linked to glioblastoma.